Share: Facebook Twitter LinkedIn
Activity Provided By:

The Rx Consultant

New Considerations in Diabetes Management

Access Activity

Overview / Abstract:

This issue highlights the use of continuous glucose monitoring (CGM) systems, sodiumglucose transport protein-2 (SGLT2) inhibitors, newer insulin formulations, and the expert guideline recommendations focused on individualization of therapy.

In 2017, the Centers for Disease Control reported that over 30 million people in the US (~10% of the population) have diabetes, including 7.2 million who are undiagnosed. The total estimated cost of diagnosed diabetes in the US was $327 billion in 2017.2 Individuals with diabetes incur average annual medical expenses of about $16,750 – more than twice the expense for people without diabetes.

Over the last decade, the options for managing diabetes have grown dramatically – including new medication classes (eg, glucagon- like peptide-1 agonists, sodium-glucose transport protein-2 inhibitors), new insulin analogs (eg, insulin degludec, biosimilar insulins), and new technologies to help patients monitor their diabetes (eg, continuous glucose monitoring).

Clinical practice guidelines have increased the emphasis on individualizing treatment options and goals to meet the needs of each patient. Patients have more say in the management of their diabetes and overall health. It is essential that healthcare providers help patients navigate the vast pool of information available at their fingertips. Diabetes patients can easily get confused by the often-conflicting information or misinformation available on television and the internet, and from friends and family members. Community providers need a good, working knowledge of patient-specific diabetes management, including current treatments and technologies...

Expiration

Sep 21, 2021

Discipline(s)

Nursing CNE, Pharmacy CPE

Format

Monograph

Cost

$6.95

Credits / Hours

1.5

Accreditation

ACPE

Presenters / Authors / Faculty

Andrew Bzowyckyj, PharmD BCPS, CDE is an Associate
Professor in the School of Pharmacy at Pacific University Oregon in
Hillsboro, Oregon.
Amanda Stahnke, PharmD, BCACP is a Clinical Assistant
Professor in the Department of Pharmacy Practice and
Administration at the University of Missouri-Kansas City School
of Pharmacy. She serves as a Patient-Aligned Care Team (PACT)
Pharmacist at the Kansas City Veterans Affairs Medical Center.
Susan Cornell, PharmD, CDE,
FAPhA, FAADE is an Associate Professor of Pharmacy Practice
and Associate Director of Experiential Education at Chicago
College of Pharmacy at Midwestern University in Downers Grove,
IL. She is also a diabetes care provider at the Bolingbrook Christian
Health Clinic and Will-Grundy Medical Clinic.

Activity Specialities / Related Topics

Diabetes

Keywords / Search Terms

Continuing Education Network Inc. diabetes, The Rx Consultant, Andrew Bzowyckyj, Amanda Stahnke, Susan Cornell, glucagon- like peptide-1 agonists, sodium-glucose transport protein-2 inhibitors, insulin degludec, biosimilar insulins, continuous glucose monitoring

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map